Lin Shao-Lee
- SEC CIK
- 0001725092
In the past year, 1 open-market sale filing worth $1.61M and no purchases.
Current role at each company
- CUE Cue Biopharma, Inc.Chief Executive Officeras of Aug 14, 2026
- SRZN Surrozen, Inc.Directoras of May 15, 2025
- SLRN ACELYRIN, Inc.Chief Executive Officeras of Apr 3, 2024
- THRD Third Harmonic Bio, Inc.Directoras of Oct 27, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.61M
- 1 filing
- Net
- −$1.61M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Lin Shao-Lee as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CUE Cue Biopharma, Inc.
Chief Executive Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 (view filing)8:46 PM ET | Aug 12-13 | 2 days | Lin Shao-LeeChief Executive Officer | SSale | −58.3K | $27.58 | −$1.61M | −7.6%706.0K after | 5 lots |
SLRN ACELYRIN, Inc.
Chief Executive Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2024 (view filing) | Apr 1 | 2 days | Lin Shao-LeeChief Executive Officer | SSale | −9.96K | $6.63 | −$66.0K | −0.6%1.58M after | |
| Feb 22, 2024 (view filing) | Feb 20 | 2 days | Lin Shao-LeeChief Executive Officer | SSale | −15.7K | $7.60 | −$119.3K | −1.0%1.59M after | |
| Jan 4, 2024 (view filing) | Jan 2 | 2 days | Lin Shao-LeeChief Executive Officer | SSale | −10.7K | $7.41 | −$79.2K | −0.7%1.60M after |